Aryl hydrocarbon receptor (AHR): “pioneer member” of the basic-helix/loop/helix per-Arnt-sim (bHLH/PAS) family of “sensors” of foreign and endogenous signals

Progress in Lipid Research

Volumn 67, Issue , 2017, Pages 38-57

  Nebert, Daniel W ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

AHR; bHLH PAS family of transcription factors; Brain gut microbiome; Cancer; Dose response curve; Eicosanoids; Embryonic stem cells; Lipid mediators; Mouse genetics; Pro inflammatory and post inflammatory response; Prostaglandins

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; BASIC HELIX LOOP HELIX PER ARNT SIM PROTEIN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CYTOCHROME P450 FAMILY 1; LIPOXYGENASE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; UNSPECIFIC MONOOXYGENASE; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; PAS DOMAIN KINASES; PROTEIN SERINE THREONINE KINASE;

AHR GENE; ARNT GENE; BONE DEVELOPMENT; CHEMICAL CARCINOGENESIS; DNA REPAIR; DNA SYNTHESIS; EMBRYONIC STEM CELL; ENZYME ACTIVITY; ENZYME INDUCTION; EXPERIMENTAL PERITONITIS; FERTILITY; FITNESS; GENE; GENE STRUCTURE; GENETIC DIFFERENCE; GRAVITY; HEAT; HEMATOPOIESIS; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; INBRED MOUSE STRAIN; INFLAMMATION; KNOCKOUT MOUSE; LONGEVITY; MOLECULAR CLONING; MUTAGENESIS; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OSMOTIC PRESSURE; OSSIFICATION; OXIDATION REDUCTION POTENTIAL; PHOTON; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; TERATOGENESIS; TOXICITY; TRANSGENIC MOUSE; UPREGULATION; ZYGOTE; ANIMAL; GENETICS; METABOLISM; PATHOLOGY;

ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; HUMANS; INFLAMMATION; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION;

EID: 85021808583     PISSN: 01637827     EISSN: 18732194     Source Type: Journal    
DOI: 10.1016/j.plipres.2017.06.001     Document Type: Review

References (222)

1. Agius, E., Bel-Vialar, S., Bonnet, F., Pituello, F., Cell cycle and cell fate in the developing nervous system: role of CDC25B phosphatase. Cell Tissue Res 359 (2015), 201–213.
2. Ahokas, J.T., Saarni, H., Nebert, D.W., Pelkonen, O., The in vitro metabolism and convalent binding of benzo[a]pyrene to DNA catalysed by trout liver microsomes. Chem Biol Interact 25 (1979), 103–111.
3. Anderson, G., Beischlag, T.V., Vinciguerra, M., Mazzoccoli, G., The circadian clock circuitry and the AHR signaling pathway in physiology and pathology. Biochem Pharmacol 85 (2013), 1405–1416.
4. Atlas, A.S., Thorgeirsson, S.S., Boobis, A.R., Kumaki, K., Nebert, D.W., Differential induction of murine Ah locus-associated monooxygenase activities in rabbit liver and kidney. Biochem Pharmacol 24 (1975), 2111–2116.
5. Atlas, S.A., Boobis, A.R., Felton, J.S., Thorgeirsson, S.S., Nebert, D.W., Ontogenetic expression of polycyclic aromatic compound-inducible monooxygenase activities and forms of cytochrome P-450 in rabbit. Evidence for temporal control and organ specificity of two genetic regulatory systems. J Biol Chem 252 (1977), 4712–4721.
6. Baker, T.R., King-Heiden, T.C., Peterson, R.E., Heideman, W., Dioxin induction of transgenerational inheritance of disease in zebrafish. Mol Cell Endocrinol 398 (2014), 36–41.
7. Barroso, A., Gualdron-Lopez, M., Esper, L., Brant, F., Araujo, R.R., Carneiro, M.B., et al., Aryl hydrocarbon receptor modulates production of cytokines and reactive oxygen species and development of myocarditis during Trypanosoma cruzi infection. Infect Immun 84 (2016), 3071–3082.
8. Bessede, A., Gargaro, M., Pallotta, M.T., Matino, D., Servillo, G., Brunacci, C., et al., Aryl hydrocarbon receptor control of a disease-tolerance-defence pathway. Nature 511 (2014), 184–190.
9. Bigelow, S.W., Collins, A.C., Nebert, D.W., Selective mouse breeding for short ethanol sleep time has led to high levels of hepatic aromatic hydrocarbon (Ah) receptor. Biochem Pharmacol 38 (1989), 3565–3572.
10. 2-terminal amino acid sequence of the Ah receptor from the C57BL/6J mouse. Mol Pharmacol 39 (1991), 13–19.
11. Bulun, S.E., Zeitoun, K.M., Kilic, G., Expression of dioxin-related transactivating factors and target genes in human eutopic endometrial and endometriotic tissues. Am J Obstet Gynecol 182 (2000), 767–775.
12. Burbach, K.M., Poland, A., Bradfield, C.A., Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc Natl Acad Sci U S A 89 (1992), 8185–8189.
13. Campbell, E.L., Serhan, C.N., Colgan, S.P., Antimicrobial aspects of inflammatory resolution in the mucosa: a role for proresolving mediators. J. Immunol. 187 (2011), 3475–3481.
14. Cella, M., Colonna, M., Aryl hydrocarbon receptor: linking environment to immunity. Semin. Immunol. 27 (2015), 310–314.
15. Céspedes, M.A., Galindo, M.I., Couso, J.P., Dioxin toxicity in vivo results from an increase in the dioxin-independent transcriptional activity of aryl hydrocarbon receptor. PLoS One, 5, 2010, e15382.
16. Chan, W.K., Yao, G., Gu, Y.Z., Bradfield, C.A., Cross-talk between aryl hydrocarbon receptor and hypoxia inducible factor signaling pathways. Demonstrated competition and compensation. J Biol Chem 274 (1999), 12115–12123.
17. Chatel, A., Faucet-Marquis, V., Gourlay-France, C., Pfohl-Leszkowicz, A., Vincent-Hubert, F., Genotoxicity and activation of cellular defenses in transplanted zebra mussels Dreissena polymorpha along the Seine river. Ecotoxicol Environ Saf 114 (2015), 241–249.
18. Cheng, J., Li, W., Kang, B., Zhou, Y., Song, J., Dan, S., et al., Tryptophan derivatives regulate Oct4 transcription in stem-like cancer cells. Nat Commun, 6, 2015, 7209.
19. Cheung, C., Gonzalez, F.J., Humanized mouse lines and their application for prediction of human drug metabolism and toxicological risk assessment. J Pharmacol Exp Ther 327 (2008), 288–299.
20. Chiaro, C.R., Patel, R.D., Perdew, G.H., 12(R)-Hydroxy-5(Z),8(Z),10(E),14(Z)-eicosatetraenoic acid [12(R)-HETE], an arachidonic acid derivative, is an activator of aryl hydrocarbon receptor. Mol Pharmacol 74 (2008), 1649–1656.
21. Collins, K.D., Lacal, J., Ottemann, K.M., Internal sense of direction: sensing and signaling from cytoplasmic chemoreceptors. Microbiol Mol Biol Rev 78 (2014), 672–684.
22. Conney, A.H., Gillette, J.R., Inscoe, J.K., Trams, E.R., Posner, H.S., Induced synthesis of liver microsomal enzymes which metabolize foreign compounds. Science 130 (1959), 1478–1479.
23. Conney, A.H., Miller, E.C., Miller, J.A., The metabolism of methylated aminoazo dyes. Evidence for induction of enzyme synthesis in the rat by 3-methylcholanthrene. Cancer Res 16 (1956), 450–459.
24. Conney, A.H., Miller, E.C., Miller, J.A., Substrate-induced synthesis and other properties of benzpyrene hydroxylase in rat liver. J Biol Chem 228 (1957), 753–766.
25. Corchero, J., Pimprale, S., Kimura, S., Gonzalez, F.J., Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation. Pharmacogenetics 11 (2001), 1–6.
26. Crews, S.T., Thomas, J.B., Goodman, C.S., The Drosophila single-minded gene encodes a nuclear protein with sequence similarity to the per gene product. Cell 52 (1988), 143–151.
27. Daiber, A., Ullrich, V., Peroxynitrite reactions with heme and heme-thiolate (P450) proteins. Methods Enzymol 359 (2002), 379–389.
28. Dalli, J., Serhan, C.N., Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. Blood 120 (2012), e60–e72.
29. de la Fuente, H., Cibrian, D., Sanchez-Madrid, F., Immunoregulatory molecules are master regulators of inflammation during the immune response. FEBS Lett 586 (2012), 2897–2905.
30. Derkenne, S., Curran, C.P., Shertzer, H.G., Dalton, T.P., Dragin, N., Nebert, D.W., Theophylline pharmacokinetics: comparison of Cyp1a1(−/−) and Cyp1a2(−/−) knockout mice, humanized hCYP1A1_1A2 knock-in mice lacking either the mouse Cyp1a1 or Cyp1a2 gene, and Cyp1(+/+) wild-type mice. Pharmacogenet Genomics 15 (2005), 503–511.
31. Dey, A., Nebert, D.W., Markedly increased constitutive Cyp1a1 mRNA levels in the fertilized ovum of the mouse. Biochem Biophys Res Commun 251 (1998), 657–661.
32. Divanovic, S., Dalli, J., Jorge-Nebert, L.F., Flick, L.M., Galvez-Peralta, M., Boespflug, N.D., et al., Contributions of the three CYP1 monooxygenases to pro-inflammatory and inflammation-resolution lipid mediator pathways. J Immunol 191 (2013), 3347–3357.
33. Do, K.N., Fink, L.N., Jensen, T.E., Gautier, L., Parlesak, A., TLR2 controls intestinal carcinogen detoxication by CYP1A1. PLoS One, 7, 2012, e32309.
34. Dolwick, K.M., Schmidt, J.V., Carver, L.A., Swanson, H.I., Bradfield, C.A., Cloning and expression of a human Ah receptor cDNA. Mol Pharmacol 44 (1993), 911–917.
35. Dragin, N., Dalton, T.P., Miller, M.L., Shertzer, H.G., Nebert, D.W., For dioxin-induced birth defects, mouse or human CYP1A2 in maternal liver protects, whereas mouse CYP1A1 and CYP1B1 are inconsequential. J Biol Chem 281 (2006), 18591–18600.
36. Dragin, N., Shi, Z., Madan, R., Karp, C.L., Sartor, M.A., Chen, C., et al., Phenotype of the Cyp1a1/1a2/1b1(−/−) triple-knockout mouse. Mol Pharmacol 73 (2008), 1844–1856.
37. Dragin, N., Uno, S., Wang, B., Dalton, T.P., Nebert, D.W., Generation of ‘humanized’ hCYP1A1_1A2_Cyp1a1/1a2(−/−) mouse line. Biochem. Biophys. Res. Commun. 359 (2007), 635–642.
38. Du, J., Liao, C., Zhou, H., Diao, X., Li, Y., Zheng, P., et al., Gene cloning and expression analysis of AHR and CYP4 from Pinctada martensii after exposure to pyrene. Ecotoxicology 24 (2015), 1574–1582.
39. Ema, M., Sogawa, K., Watanabe, N., Chujoh, Y., Matsushita, N., Gotoh, O., et al., cDNA cloning and structure of mouse putative Ah receptor. Biochem. Biophys. Res. Commun. 184 (1992), 246–253.
40. Emmons, R.B., Duncan, D., Estes, P.A., Kiefel, P., Mosher, J.T., Sonnenfeld, M., et al., The spineless-aristapedia and tango bHLH-PAS proteins interact to control antennal and tarsal development in Drosophila. Development 126 (1999), 3937–3945.
41. Ernster, L., Orrenius, S., Substrate-induced synthesis of the hydroxylating enzyme system of liver microsomes. Fed Proc 24 (1965), 1190–1199.
42. Esser, C., Rannug, A., The aryl hydrocarbon receptor in barrier organ physiology, immunology, and toxicology. Pharmacol Rev 67 (2015), 259–279.
43. Felker, A.M., Chen, Z., Foster, W.G., Croy, B.A., Receptors for non-MHC ligands contribute to uterine natural killer cell activation during pregnancy in mice. Placenta 34 (2013), 757–764.
44. Fernandez-Salguero, P., Pineau, T., Hilbert, D.M., McPhail, T., Lee, S.S., Kimura, S., et al., Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding AH receptor. Science 268 (1995), 722–726.
45. Fernandez-Salguero, P.M., Hilbert, D.M., Rudikoff, S., Ward, J.M., Gonzalez, F.J., Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol Appl Pharmacol 140 (1996), 173–179.
46. Fornace, A.J. Jr., Nebert, D.W., Hollander, M.C., Luethy, J.D., Papathanasiou, M., Fargnoli, J., et al., Mammalian genes coordinately regulated by growth-arrest signals and DNA-damaging agents. Mol Cell Biol 9 (1989), 4196–4203.
47. Fracchiolla, N.S., Annaloro, C., Guidotti, F., Fattizzo, B., Cortelezzi, A., 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) role in hematopoiesis and in hematologic diseases: a critical review. Toxicology 374 (2016), 60–68.
48. Galloway, S.M., Perry, P.E., Meneses, J., Nebert, D.W., Pedersen, R.A., Cultured mouse embryos metabolize benzo[a]pyrene during early gestation: genetic differences detectable by sister chromatid exchange. Proc. Natl. Acad. Sci. U. S. A. 77 (1980), 3524–3528.
49. Gasiewicz, T.A., Singh, K.P., Bennett, J.A., The Ah receptor in stem cell cycling, regulation, and quiescence. Ann. N. Y. Acad. Sci. 1310 (2014), 44–50.
50. Ge, N.L., Elferink, C.J., A direct interaction between aryl hydrocarbon receptor and retinoblastoma protein. Linking dioxin signaling to the cell cycle. J Biol Chem 273 (1998), 22708–22713.
51. Gielen, J.E., Goujon, F.M., Nebert, D.W., Genetic regulation of aryl hydrocarbon hydroxylase induction. Simple Mendelian expression in mouse tissues in vivo. J Biol Chem 247 (1972), 1125–1137.
52. Glaumann, H., Kuylenstierna, B., Dallner, G., Differential distribution of cytochrome P-450 and cytochrome P-448 in liver microsomal membranes. Life Sci 8 (1969), 1309–1315.
53. Gooley, J.J., Circadian regulation of lipid metabolism. Proc Nutr Soc 75 (2016), 440–450.
54. Goossens, J., Mertens, J., Goossens, A., Role and functioning of bHLH transcription factors in jasmonate signaling. J Exp Bot, 68, 2017, erw440.
55. Greene, E.R., Huang, S., Serhan, C.N., Panigrahy, D., Regulation of inflammation in cancer by eicosanoids. Prostaglandins Other Lipid Mediat 96 (2011), 27–36.
56. Grunwald, S., Niedermeier, J., Wenzel, U., Hormesis is induced in the red flour beetle Tribolium castaneum through ingestion of charred toast. Eur J Nutr 54 (2015), 535–541.
57. Hahn, M.E., Karchner, S.I., Evans, B.R., Franks, D.G., Merson, R.R., Lapseritis, J.M., Unexpected diversity of aryl hydrocarbon receptors in non-mammalian vertebrates: insights from comparative genomics. J Exp Zool A Comp Exp Biol 305 (2006), 693–706.
58. Hankinson, O., Single-step selection of clones of a mouse hepatoma line deficient in aryl hydrocarbon hydroxylase. Proc Natl Acad Sci U S A 76 (1979), 373–376.
59. Hankinson, O., The role of AHR-inducible cytochrome P450s in metabolism of polyunsaturated fatty acids. Drug Metab Rev 48 (2016), 342–350.
60. 1-450 gene in the mouse Hepa-1 cell line. J Biol Chem 260 (1985), 1790–1795.
61. Hao, N., Bhakti, V.L., Peet, D.J., Whitelaw, M.L., Reciprocal regulation of the basic helix-loop-helix/PER-ARNT-SIM partner proteins, ARNT and ARNT2, during neuronal differentiation. Nucleic Acids Res 41 (2013), 5626–5638.
62. Harstad, E.B., Guite, C.A., Thomae, T.L., Bradfield, C.A., Liver deformation in Ahr-null mice: evidence for aberrant hepatic perfusion in early development. Mol Pharmacol 69 (2006), 1534–1541.
63. Hayaishi, O., Katagiri, M., Rothberg, S., Mechanism of the pyrocatechase reaction. J Am Chem Soc 77 (1955), 5450–5451.
64. Henry, J.T., Crosson, S., Ligand-binding PAS domains in a genomic, cellular, and structural context. Annu Rev Microbiol 65 (2011), 261–286.
65. Herlin, M., Finnila, M.A., Zioupos, P., Aula, A., Risteli, J., Miettinen, H.M., et al., New insights to the role of aryl hydrocarbon receptor in bone phenotype and in dioxin-induced modulation of bone microarchitecture and material properties. Toxicol Appl Pharmacol 273 (2013), 219–226.
66. Hernandez-Ochoa, I., Karman, B.N., Flaws, J.A., The role of aryl hydrocarbon receptor in the female reproductive system. Biochem Pharmacol 77 (2009), 547–559.
67. Hoffman, E.C., Reyes, H., Chu, F.F., Sander, F., Conley, L.H., Brooks, B.A., et al., Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 252 (1991), 954–958.
68. Hou, P., Li, Y., Zhang, X., Liu, C., Guan, J., Li, H., et al., Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 341 (2013), 651–654.
69. Huang, B., Butler, R., Miao, Y., Dai, Y., Wu, W., Su, W., et al., Dysregulation of notch- and ESR1-signaling in Ahr(−/−) male mice. Proc Natl Acad Sci U S A 113 (2016), 11883–11888.
70. Hubbard, T.D., Murray, I.A., Perdew, G.H., Indole and tryptophan metabolism: endogenous and dietary routes to AH receptor activation. Drug Metab Dispos 43 (2015), 1522–1535.
71. Husain, S., Kaddour-Djebbar, I., Abdel-Latif, A.A., Alterations in arachidonic acid release and phospholipase Cβ1 expression in glaucomatous human ciliary muscle cells. Invest Ophthalmol Vis Sci 43 (2002), 1127–1134.
72. Ichihara, S., Yamada, Y., Ichihara, G., Nakajima, T., Li, P., Kondo, T., et al., A role for aryl hydrocarbon receptor in regulation of ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol 27 (2007), 1297–1304.
73. Ikuta, T., Kurosumi, M., Yatsuoka, T., Nishimura, Y., Tissue distribution of aryl hydrocarbon receptor in the intestine: implication of putative roles in tumor suppression. Exp Cell Res 343 (2016), 126–134.
74. Ikuta, T., Namiki, T., Fujii-Kuriyama, Y., Kawajiri, K., AHR protein trafficking and function in the skin. Biochem Pharmacol 77 (2009), 588–596.
75. Iqbal, J., Sun, L., Cao, J., Yuen, T., Lu, P., Bab, I., et al., Smoke carcinogens cause bone loss through aryl hydrocarbon receptor and induction of CYP1 enzymes. Proc Natl Acad Sci U S A 110 (2013), 11115–11120.
76. Ito, S., Chen, C., Satoh, J., Yim, S., Gonzalez, F.J., Dietary phytochemicals regulate whole-body CYP1A1 expression through an aryl hydrocarbon receptor nuclear translocator-dependent system in gut. J Clin Invest 117 (2007), 1940–1950.
77. Izawa, T., Arakaki, R., Mori, H., Tsunematsu, T., Kudo, Y., Tanaka, E., et al., Nuclear receptor AHR controls bone homeostasis by regulating osteoclast differentiation via the RANK/c-FOS signaling Axis. J Immunol 197 (2016), 4639–4650.
78. Jaeger, C., Tischkau, S.A., Role of aryl hydrocarbon receptor in circadian clock disruption and metabolic dysfunction. Environ Health Insights 10 (2016), 133–141.
79. Ji, R.R., Xu, Z.Z., Strichartz, G., Serhan, C.N., Emerging roles of resolvins in the resolution of inflammation and pain. Trends Neurosci 34 (2011), 599–609.
80. Jiang, Z., Dalton, T.P., Jin, L., Wang, B., Tsuneoka, Y., Shertzer, H.G., et al., Toward the evaluation of function in genetic variability: characterizing human SNP frequencies and establishing BAC-transgenic mice carrying the human CYP1A1_CYP1A2 locus. Hum Mutat 25 (2005), 196–206.
81. Kee, K., Flores, M., Cedars, M.I., Reijo Pera, R.A., Human primordial germ cell formation is diminished by exposure to environmental toxicants acting through the AHR signaling pathway. Toxicol Sci 117 (2010), 218–224.
82. Kim, B.M., Rhee, J.S., Hwang, U.K., Seo, J.S., Shin, K.H., Lee, J.S., Dose- and time-dependent expression of aryl hydrocarbon receptor (AHR) and aryl hydrocarbon receptor nuclear translocator (ARNT) in PCB-, B[a]P-, and TBT-exposed intertidal copepod Tigriopus japonicus. Chemosphere 120 (2015), 398–406.
83. 1450 gene during differentiation without foreign chemical stimulation. J Exp Pathol 3 (1987), 61–74.
84. 3-450 cDNA nucleotide and amino acid sequences. J Biol Chem 259 (1984), 10705–10713.
85. 2-450. Nucleic Acids Res 14 (1986), 6765–6766.
86. 1450 gene via cDNA expression in yeast. EMBO J 6 (1987), 1929–1933.
87. Ko, C.I., Fan, Y., de, G. M., Wang, Q., Xia, Y., and Puga, A., Repression of aryl hydrocarbon receptor is required to maintain mitotic progression and prevent loss of pluripotency of embryonic stem cells. Stem Cells 34 (2016), 2825–2839.
88. Ko, C.I., Wang, Q., Fan, Y., Xia, Y., Puga, A., Pluripotency factors and polycomb group proteins repress aryl hydrocarbon receptor expression in mouse embryonic stem cells. Stem Cell Res 12 (2014), 296–308.
89. 32P-postlabeling and use of Ahr-null knockout mice for mechanisms of metabolic activation in liver. Int J Cancer 103 (2003), 5–11.
90. Konopka, R.J., Benzer, S., Clock mutants of Drosophila melanogaster. Proc Natl Acad Sci U S A 68 (1971), 2112–2116.
91. Kreitinger, J.M., Beamer, C.A., Shepherd, D.M., Environmental immunology: lessons learned from exposure to a select panel of immunotoxicants. J Immunol 196 (2016), 3217–3225.
92. Krock, B.L., Eisinger-Mathason, T.S., Giannoukos, D.N., Shay, J.E., Gohil, M., Lee, D.S., et al., Aryl hydrocarbon receptor nuclear translocator (ARNT) is an essential regulator of mouse hematopoietic stem cell viability. Blood 125 (2015), 3263–3272.
93. Kühn, H., Wiesner, R., Alder, L., Fitzsimmons, B. J., Rokach, J., Brash, A. R., and A (1987) Formation of lipoxin B by the pure reticulocyte lipoxygenase via sequential oxygenation of the substrate. Eur J Biochem 169, 593–601.
94. Kuroda, M., Oikawa, K., Ohbayashi, T., Yoshida, K., Yamada, K., Mimura, J., et al., A dioxin-sensitive gene, mammalian WAPL, is implicated in spermatogenesis. FEBS Lett 579 (2005), 167–172.
95. Lahvis, G.P., Bradfield, C.A., Ahr null alleles: distinctive or different?. Biochem Pharmacol 56 (1998), 781–787.
96. Lahvis, G.P., Pyzalski, R.W., Glover, E., Pitot, H.C., McElwee, M.K., Bradfield, C.A., Aryl hydrocarbon receptor is required for developmental closure of the ductus venosus in the neonatal mouse. Mol Pharmacol 67 (2005), 714–720.
97. Lamas, B., Richard, M.L., Leducq, V., Pham, H.P., Michel, M.L., Da, C.G., et al., CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat Med 22 (2016), 598–605.
98. Latchney, S.E., Lioy, D.T., Henry, E.C., Gasiewicz, T.A., Strathmann, F.G., Mayer-Proschel, M., et al., Neural precursor cell proliferation is disrupted through activation of aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Stem Cells Dev 20 (2011), 313–326.
99. Le Beau, M.M., Carver, L.A., Espinosa, R. III, Schmidt, J.V., Bradfield, C.A., Chromosomal localization of the human AHR locus encoding the structural gene for the Ah receptor to 7p21 → p15. Cytogenet. Cell Genet 66 (1994), 172–176.
100. Lee, H.U., McPherson, Z.E., Tan, B., Korecka, A., Pettersson, S., Host-microbiome interactions: aryl hydrocarbon receptor and the central nervous system. J Mol Med, 2016 (Berl) xx, 2016 Nov 17. [Epub ahead of print].
101. Legraverend, C., Hannah, R.R., Eisen, H.J., Owens, I.S., Nebert, D.W., Hankinson, O., Regulatory gene product of the Ah locus. Characterization of receptor mutants among mouse hepatoma clones. J Biol Chem 257 (1982), 6402–6407.
102. Li, N., Zhou, Y., Du, L., Wei, M., Chen, X., Overview of CYP1B1 gene mutations in patients with primary congenital glaucoma. Exp. Eye Res 93 (2011), 572–579.
103. Libby, R.T., Smith, R.S., Savinova, O.V., Zabaleta, A., Martin, J.E., Gonzalez, F.J., et al., Modification of ocular defects in mouse developmental glaucoma models by tyrosinase. Science 299 (2003), 1578–1581.
104. Lin, C., Todo, T., The cryptochromes. Genome Biol, 6, 2005, 220.
105. Lindsey, S., Papoutsakis, E.T., The evolving role of aryl hydrocarbon receptor (AHR) in normophysiology of hematopoiesis. Stem Cell Rev 8 (2012), 1223–1235.
106. Lu, A.Y., Kuntzman, R., West, S., Conney, A.H., Reconstituted liver microsomal enzyme system that hydroxylates drugs, other foreign compounds and endogenous substrates. Determination of substrate specificity by the cytochrome P-450 and P-448 fractions. Biochem Biophys Res Commun 42 (1971), 1200–1206.
107. Luna, R.A., Savidge, T.C., Williams, K.C., The brain-gut-microbiome axis: what role does it play in autism spectrum disorder?. Curr Dev Disord Rep 3 (2016), 75–81.
108. Maezawa, K., Miyazato, K., Matsunaga, T., Momose, Y., Imamura, T., Johkura, K., et al., Expression of cytochrome P450 and transcription factors during in vitro differentiation of mouse embryonic stem cells into hepatocytes. Drug Metab Pharmacokinet 23 (2008), 188–195.
109. Marinkovic, N., Pasalic, D., Potocki, S., Polymorphisms of genes involved in polycyclic aromatic hydrocarbon biotransformation and atherosclerosis. Biochem Med 23 (2013), 255–265.
110. Mas, E., Croft, K.D., Zahra, P., Barden, A., Mori, T.A., Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following ω-3 fatty acid supplementation. Clin Chem 58 (2012), 1476–1484.
111. Mason, H.S., Mechanisms of oxygen metabolism. Science 125 (1957), 1185–1188.
112. Mason, H.S., Fowlkes, W.L., Peterson, E., Oxygen transfer and electron transport by the phenolase complex. J Am Chem Soc 77 (1955), 2914–2915.
113. Mason, H.S., North, J.C., Vanneste, M., Microsomal mixed-function oxidations: the metabolism of xenobiotics. Fed Proc 24 (1965), 1172–1180.
114. Mazzoli, R., Pessione, E., The neuro-endocrinological role of microbial glutamate and GABA signaling. Front Microbiol, 7, 2016, 1934.
115. Mellor, C.L., Steinmetz, F.P., Cronin, M.T., Identification of nuclear receptors associated with hepatic steatosis to develop and extend adverse outcome pathways. Crit Rev Toxicol 46 (2016), 138–152.
116. Moura-Alves, P., Fae, K., Houthuys, E., Dorhoi, A., Kreuchwig, A., Furkert, J., et al., AHR sensing of bacterial pigments regulates antibacterial defence. Nature 512 (2014), 387–392.
117. Mulero-Navarro, S., Fernandez-Salguero, P.M., New trends in aryl hydrocarbon receptor biology. Front Cell Dev Biol, 4, 2016, 45.
118. Nambu, J.R., Lewis, J.O., Wharton, K.A. Jr., Crews, S.T., Drosophila single-minded gene encodes a helix-loop-helix protein that acts as a master regulator of CNS midline development. Cell 67 (1991), 1157–1167.
119. Nanez, A., Ramos, I.N., Ramos, K.S., A mutant Ahr allele protects the embryonic kidney from hydrocarbon-induced deficits in fetal programming. Environ Health Perspect 119 (2011), 1745–1753.
120. Nault, R., Fader, K.A., Lydic, T.A., Zacharewski, T.R., Lipidomic evaluation of aryl hydrocarbon receptor-mediated hepatic steatosis in male and female mice elicited by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Chem Res Toxicol 30 (2017), 1060–1075.
121. 5 and P450 during induction of aryl hydrocarbon hydroxylase activity in mammalian cell culture. J Biol Chem 245 (1970), 519–527.
122. Nebert, D.W., The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects. Crit Rev Toxicol 20 (1989), 153–174.
123. Nebert, D.W., Drug metabolism and signal transduction: possible role of Ah receptor and arachidonic acid cascade in protection from ethanol toxicity. EXS 71 (1994), 231–240.
124. Nebert, D.W., Brown, D.D., Towne, D.W., Eisen, H.J., Association of fertility, fitness and longevity with the mouse Ah locus among C57BL/6N x C3H/HeN recombinant inbred lines. Biol Reprod 30 (1984), 363–373.
125. Nebert, D.W., Dalton, T.P., The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat Rev Cancer 6 (2006), 947–960.
126. Nebert, D.W., Dalton, T.P., Okey, A.B., Gonzalez, F.J., Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem 279 (2004), 23847–23850.
127. Nebert, D.W., Eisen, H.J., Negishi, M., Lang, M.A., Hjelmeland, L.M., Okey, A.B., Genetic mechanisms controlling the induction of polysubstrate monooxygenase (P-450) activities. Annu Rev Pharmacol Toxicol 21 (1981), 431–462.
128. Nebert, D.W., Gálvez-Peralta, M., Shi, Z., Dragin, N., Inbreeding and epigenetics: beneficial as well as deleterious effects. Nat Rev Genet, 11, 2010, 662.
129. Nebert, D.W., Gelboin, H.V., Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture. I. Assay and properties of induced enzyme. J Biol Chem 243 (1968), 6242–6249.
130. Nebert, D.W., Gelboin, H.V., Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture. II. Cellular responses during enzyme induction. J Biol Chem 243 (1968), 6250–6261.
131. Nebert, D.W., Gelboin, H.V., In vivo and in vitro induction of aryl hydrocarbon hydroxylase in mammalian cells of different species, tissues, strains, and developmental and hormonal states. Arch. Biochem. Biophys. 134 (1969), 76–89.
132. Nebert, D.W., Gelboin, H.V., Role of ribonucleic acid and protein synthesis in microsomal aryl hydrocarbon hydroxylase induction in cell culture. The independence of transcription and translation. J Biol Chem 245 (1970), 160–168.
133. Nebert, D.W., Goujon, F.M., Gielen, J.E., Aryl hydrocarbon hydroxylase induction by polycyclic hydrocarbons: simple autosomal dominant trait in the mouse. Nat New Biol 236 (1972), 107–110.
134. Nebert, D.W., Karp, C.L., Endogenous functions of aryl hydrocarbon receptor (AHR): intersection of cytochrome P450 1 (CYP1)-metabolized eicosanoids and AHR biology. J Biol Chem 283 (2008), 36061–36065.
135. Nebert, D.W., Roe, A.L., Dieter, M.Z., Solis, W.A., Yang, Y., Dalton, T.P., Role of aromatic hydrocarbon receptor and [Ahr] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem Pharmacol 59 (2000), 65–85.
136. Nebert, D.W., Shi, Z., Gálvez-Peralta, M., Uno, S., Dragin, N., Oral benzo[a]pyrene: understanding pharmacokinetics, detoxication, and consequences—Cyp1 knockout mouse lines as a paradigm. Mol Pharmacol 84 (2013), 304–313.
137. Nebert, D.W., Wikvall, K., Miller, W.L., Human cytochromes P450 in health and disease. Philos. Trans. R. Soc. Lond B Biol Sci., 368, 2013, 20120431.
138. Nebert, D.W., Winker, J., Gelboin, H.V., Aryl hydrocarbon hydroxylase activity in human placenta from cigarette smoking and nonsmoking women. Cancer Res 29 (1969), 1763–1769.
139. Nelson, D.R., Koymans, L., Kamataki, T., Stegeman, J.J., Feyereisen, R., Waxman, D.J., et al., P450 superfamily: update on new sequences, gene mapping, accession numbers, and nomenclature. Pharmacogenetics 6 (1996), 1–42.
140. Nelson, D.R., Zeldin, D.C., Hoffman, S.M., Maltais, L.J., Wain, H.M., Nebert, D.W., Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 14 (2004), 1–18.
141. Neri, T., Merico, V., Garagna, S., Redi, C.A., Zuccotti, M., Expression of phase I and phase II genes in mouse embryonic stem cells cultured in the presence of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochim Biophys Acta 1780 (2008), 826–836.
142. Newton, W.A., Snell, E.E., Formation and interrelationships of tryptophanase and tryptophan synthetases in Escherichia coli. J Bacteriol 89 (1965), 355–364.
143. Nguyen, L.P., Bradfield, C.A., The search for endogenous activators of the aryl hydrocarbon receptor. Chem Res Toxicol 21 (2008), 102–116.
144. Nomura, T., Kabashima, K., Advances in atopic dermatitis in 2015. J Allergy Clin Immunol 138 (2016), 1548–1555.
145. Okey, A.B., An aryl hydrocarbon receptor odyssey to the shores of toxicology: the Deichmann lecture, international congress of toxicology-XI. Toxicol Sci 98 (2007), 5–38.
146. Omura, T., Sato, R., A new cytochrome in liver microsomes. J Biol Chem 237 (1962), 1375–1376.
147. Omura, T., Sato, R., The carbon monoxide-binding pigment of liver microsomes. Evidence for its hemoprotein nature. J Biol Chem 239 (1964), 2370–2378.
148. Omura, T., Sato, R., Cooper, D.Y., Rosenthal, O., Estabrook, R.W., Function of cytochrome P-450 of microsomes. Fed Proc 24 (1965), 1181–1189.
149. Paine, A.J., Comparison of the photochemical and enzymic generation of excited states of oxygen on the induction of benzo[a]pyrene mon-oxygenase activity in liver cell cultures. Chem Biol Interact 16 (1977), 309–314.
150. Panigrahy, D., Edin, M.L., Lee, C.R., Huang, S., Bielenberg, D.R., Butterfield, C.E., et al., Epoxyeicosanoids stimulate multiorgan metastasis, and tumor dormancy escape, in mice. J Clin Invest 122 (2012), 178–191.
151. 1–450. Mol Pharmacol 6 (1970), 178–183.
152. Patel, S.A., Velingkaar, N.S., Kondratov, R.V., Transcriptional control of antioxidant defense by the circadian clock. Antioxid Redox Signal 20 (2014), 2997–3006.
153. Pecenova, L., Farkas, R., Multiple functions and essential roles of nuclear receptor coactivators of bHLH-PAS family. Endocr Regul 50 (2016), 165–181.
154. Pellequer, J.L., Wager-Smith, K.A., Kay, S.A., Getzoff, E.D., Photoactive yellow protein: a structural prototype for the three-dimensional fold of the PAS domain superfamily. Proc Natl Acad Sci U S A. 95 (1998), 5884–5890.
155. Pernomian, L., da Silva, C.H., Current basis for discovery and development of aryl hydrocarbon receptor antagonists for experimental and therapeutic use in atherosclerosis. Eur J Pharmacol 764 (2015), 118–123.
156. Poland, A., Glover, E., 2,3,7,8-Tetrachlorodibenzo-p-dioxin: a potent inducer of δ-aminolevulinic acid synthetase. Science 179 (1973), 476–477.
157. Poland, A., Glover, E., Chlorinated biphenyl induction of aryl hydrocarbon hydroxylase activity: study of the structure-activity relationship. Mol Pharmacol 13 (1977), 924–938.
158. Poland, A., Glover, E., Kende, A.S., Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. J Biol Chem 251 (1976), 4936–4946.
159. 1-450 formation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice genetically “nonresponsive” to other aromatic hydrocarbons. J Biol Chem 249 (1974), 5599–5606.
160. Powell-Coffman, J.A., Bradfield, C.A., Wood, W.B., Caenorhabditis elegans orthologs of aryl hydrocarbon receptor and its heterodimerization partner, aryl hydrocarbon receptor nuclear translocator. Proc Natl Acad Sci U S A 95 (1998), 2844–2849.
161. Probst, M.R., Fan, C.M., Tessier-Lavigne, M., Hankinson, O., Two mouse homologs of the Drosophila single-minded protein that interact with mouse aryl hydrocarbon receptor nuclear translocator protein. J Biol Chem 272 (1997), 4451–4457.
162. Prochazkova, J., Kabatkova, M., Smerdova, L., Pachernik, J., Sykorova, D., Kohoutek, J., et al., Aryl hydrocarbon receptor negatively regulates expression of the plakoglobin gene (jup). Toxicol Sci 134 (2013), 258–270.
163. Proctor, K.G., Falck, J.R., Capdevila, J., Intestinal vasodilation by epoxyeicosatrienoic acids: arachidonic acid metabolites produced by a cytochrome P450 monooxygenase. Circ Res 60 (1987), 50–59.
164. Puga, A., Barnes, S.J., Dalton, T.P., Chang, C., Knudsen, E.S., Maier, M.A., Aromatic hydrocarbon receptor interaction with retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest. J Biol Chem 275 (2000), 2943–2950.
165. Puga, A., Ma, C., Marlowe, J.L., Aryl hydrocarbon receptor cross-talks with multiple signal-transduction pathways. Biochem Pharmacol 77 (2009), 713–722.
166. Qi, Y., Tian, X., Liu, J., Han, Y., Graham, A.M., Simon, M.C., et al., BNIP3 and AIF cooperate to induce apoptosis and cavitation during epithelial morphogenesis. J Cell Biol 198 (2012), 103–114.
167. + group 3 ILCs and controls intestinal immunity and inflammation. Semin Immunopathol 35 (2013), 657–670.
168. Rahmioglu, N., Nyholt, D.R., Morris, A.P., Missmer, S.A., Montgomery, G.W., Zondervan, K.T., Genetic variants underlying risk of endometriosis: insights from meta-analysis of eight genome-wide association and replication datasets. Hum Reprod Update 20 (2014), 702–716.
169. Reitzel, A.M., Passamaneck, Y.J., Karchner, S.I., Franks, D.G., Martindale, M.Q., Tarrant, A.M., et al., Aryl hydrocarbon receptor (AHR) in the cnidarian Nematostella vectensis: comparative expression, protein interactions, and ligand-binding. Dev Genes Evol 224 (2014), 13–24.
170. Rentas, S., Holzapfel, N.T., Belew, M.S., Pratt, G.A., Voisin, V., Wilhelm, B.T., et al., Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells. Nature 532 (2016), 508–511.
171. Rier, S.E., Turner, W.E., Martin, D.C., Morris, R., Lucier, G.W., Clark, G.C., Serum levels of TCDD and dioxin-like chemicals in rhesus monkeys chronically exposed to dioxin: correlation of increased serum PCB levels with endometriosis. Toxicol Sci 59 (2001), 147–159.
172. Rifkind, A.B., Muschick, H., Benoxaprofen suppression of polychlorinated biphenyl toxicity without alteration of mixed-function oxidase function. Nature 303 (1983), 524–526.
173. Robertson, J.A., Hankinson, O., Nebert, D.W., Autoregulation plus positive and negative elements controlling transcription of genes in the [Ah] battery. Chem Scripta 27A (1987), 83–87.
174. Robinson, J.R., Considine, N., Nebert, D.W., Genetic expression of aryl hydrocarbon hydroxylase induction. Evidence for involvement of other genetic loci. J Biol Chem 249 (1974), 5851–5859.
175. Sabatini, P.V., Lynn, F.C., All-encomPASsing regulation of beta-cells: PAS domain proteins in beta-cell dysfunction and diabetes. Trends Endocrinol Metab 26 (2015), 49–57.
176. Safe, S.H., Pallaroni, L., Yoon, K., Gaido, K., Ross, S., McDonnell, D., Problems for risk assessment of endocrine-active estrogenic compounds. Environ Health Perspect 110:Suppl. 6 (2002), 925–929.
177. Safe, T.M., Luebke, A.E., Prenatal low-dosage dioxin (TCDD) exposure impairs cochlear function resulting in auditory neuropathy. Hear Res 331 (2016), 7–12.
178. Samuelsson, B., Role of basic science in the development of new medicines: examples from the eicosanoid field. J Biol Chem 287 (2012), 10070–10080.
179. Sauzeau, V., Carvajal-Gonzalez, J.M., Riolobos, A.S., Sevilla, M.A., Menacho-Marquez, M., Roman, A.C., et al., AHR transcriptional factor controls cardiovascular and respiratory functions by regulating expression of the Vav3 proto-oncogene. J Biol Chem 286 (2011), 2896–2909.
180. Sauzeau, V., Carvajal-Gonzalez, J.M., Riolobos, A.S., Sevilla, M.A., Menacho-Marquez, M., Roman, A.C., et al., Transcriptional factor aryl hydrocarbon receptor (AHR) controls cardiovascular and respiratory functions by regulating expression of the Vav3 proto-oncogene. J Biol Chem 286 (2011), 2896–2909.
181. 4: a new class of ligand for the Ah receptor. Biochemistry 38 (1999), 7594–7600.
182. Scheer, N., Wilson, I.D., A comparison between genetically humanized and chimeric liver humanized mouse models for studies in drug metabolism and toxicity. Drug Discov Today 21 (2016), 250–263.
183. Scheer, N., Wolf, C.R., Genetically humanized mouse models of drug-metabolizing enzymes and transporters and their applications. Xenobiotica 44 (2014), 96–108.
184. Schiering, C., Wincent, E., Metidji, A., Iseppon, A., Li, Y., Potocnik, A.J., et al., Feedback control of AHR signalling regulates intestinal immunity. Nature 542 (2016), 242–245.
185. Schmidt, J.V., Carver, L.A., Bradfield, C.A., Molecular characterization of the mouse Ahr gene. Organization, promoter analysis, and chromosomal assignment. J. Biol. Chem. 268 (1993), 22203–22209.
186. Schneider, A.J., Branam, A.M., Peterson, R.E., Intersection of AHR and WNT-signaling in development, health, and disease. Int J Mol Sci 15 (2014), 17852–17885.
187. Senft, A.P., Dalton, T.P., Nebert, D.W., Genter, M.B., Hutchinson, R.J., Shertzer, H.G., Dioxin increases reactive oxygen production in mouse liver mitochondria. Toxicol Appl Pharmacol 178 (2002), 15–21.
188. Senft, A.P., Dalton, T.P., Nebert, D.W., Genter, M.B., Puga, A., Hutchinson, R.J., et al., Mitochondrial reactive oxygen production is dependent on aryl hydrocarbon receptor. Free Radic Biol Med 33 (2002), 1268–1278.
189. Serhan, C.N., Fredman, G., Yang, R., Karamnov, S., Belayev, L.S., Bazan, N.G., et al., Novel proresolving aspirin-triggered DHA pathway. Chem Biol 18 (2011), 976–987.
190. Serhan, C.N., Lu, Y., Hong, S., Yang, R., Mediator lipidomics: search algorithms for eicosanoids, resolvins, and protectins. Methods Enzymol 432 (2007), 275–317.
191. Shadfan, M., Lopez-Pajares, V., Yuan, Z.M., MDM2 and MDM4: alone and together in regulation of TP53. Transl Cancer Res 1 (2012), 88–89.
192. Shertzer, H.G., Nebert, D.W., Puga, A., Ary, M., Sonntag, D., Dixon, K., et al., Dioxin causes a sustained oxidative stress response in the mouse. Biochem. Biophys. Res. Commun. 253 (1998), 44–48.
193. d mouse line harboring the poor-affinity aryl hydrocarbon receptor. Biochem Biophys Res Commun 376 (2008), 775–780.
194. Shichi, H., Nebert, D.W., Genetic differences in drug metabolism associated with ocular toxicity. Environ Health Perspect 44 (1982), 107–117.
195. Shimizu, Y., Nakatsuru, Y., Ichinose, M., Takahashi, Y., Kume, H., Mimura, J., et al., Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc Natl Acad Sci U S A 97 (2000), 779–782.
196. Shum, S., Jensen, N.M., Nebert, D.W., The mouse Ah locus: in utero toxicity and teratogenesis associated with genetic differences in benzo[a]pyrene metabolism. Teratology 20 (1979), 365–376.
197. Sofo, V., Gotte, M., Lagana, A.S., Salmeri, F.M., Triolo, O., Sturlese, E., et al., Correlation between dioxin and endometriosis: an epigenetic route to unravel the pathogenesis of the disease. Arch. Gynecol. Obstet. 292 (2015), 973–986.
198. Soshilov, A.A., Denison, M.S., Ligand promiscuity of aryl hydrocarbon receptor agonists and antagonists revealed by site-directed mutagenesis. Mol Cell Biol 34 (2014), 1707–1719.
199. Strittmatter, P., Velick, S.F., The purification and properties of microsomal cytochrome reductase. J Biol Chem 228 (1957), 785–799.
200. Tohyama, C., Clarification of molecular targets of dioxin toxicity. Nihon Eiseigaku Zasshi 69 (2014), 1–7.
201. 1-450 mRNA. Cell 31 (1982), 275–284.
202. Uno, S., Sakurai, K., Nebert, D.W., Makishima, M., Protective role of cytochrome P450 1A1 (CYP1A1) against benzo[a]pyrene-induced toxicity in mouse aorta. Toxicology 316 (2014), 34–42.
203. Vogt, J.H., Schippers, J.H., Setting the PAS, the role of circadian PAS domain proteins during environmental adaptation in plants. Front Plant Sci, 6, 2015, 513.
204. Volotinen, M., Maenpaa, J., Kankuri, E., Oksala, O., Pelkonen, O., Nakajima, M., et al., Expression of cytochrome P450 (CYP) enzymes in human nonpigmented ciliary epithelial cells: induction of CYP1B1 expression by TCDD. Invest Ophthalmol Vis Sci 50 (2009), 3099–3105.
205. Vorrink, S.U., Domann, F.E., Regulatory crosstalk and interference between xenobiotic- and hypoxia-sensing pathways at the AHR-ARNT-HIF1α signaling node. Chem Biol Interact 218 (2014), 82–88.
206. Wang, Q., Chen, J., Ko, C.I., Fan, Y., Carreira, V., Chen, Y., et al., Disruption of aryl hydrocarbon receptor homeostatic levels during ES stem cell differentiation alters expression of homeobox transcription factors that control cardiomyogenesis. Environ Health Perspect 121 (2013), 1334–1343.
207. Wang, Q., Kurita, H., Carreira, V., Ko, C.I., Fan, Y., Zhang, X., et al., AHR activation by dioxin disrupts activin, BMP, and WNT signals during early differentiation of mouse embryonic stem cells and inhibits cardiomyocyte functions. Toxicol Sci 149 (2016), 346–357.
208. Wattenberg, L.W., Leong, J.L., Strand, P.J., Benzpyrene hydroxylase activity in the gastrointestinal tract. Cancer Res 22 (1962), 1120–1125.
209. Welch, R.M., Harrison, Y.E., CONNEY, A.H., Poppers, P.J., Finster, M., Cigarette smoking: stimulatory effect on metabolism of 3,4-benzpyrene by enzymes in human placenta. Science 160 (1968), 541–542.
210. Wells, P.G., Lee, C.J., McCallum, G.P., Perstin, J., Harper, P.A., Receptor- and reactive intermediate-mediated mechanisms of teratogenesis. Handb Exp Pharmacol 196 (2010), 131–162.
211. Wimuttisuk, W., Tobwor, P., Deenarn, P., Danwisetkanjana, K., Pinkaew, D., Kirtikara, K., et al., Insights into the prostanoid pathway in ovary development of the penaeid shrimp Penaeus monodon. PLoS One, 8, 2013, e76934.
212. Wlodarchak, N., Xing, Y., PP2A as a master regulator of the cell cycle. Crit Rev Biochem Mol Biol 51 (2016), 162–184.
213. Woeller, C.F., Roztocil, E., Hammond, C.L., Feldon, S.E., Phipps, R.P., Aryl hydrocarbon receptor and its ligands inhibit myofibroblast formation and activation: implications for thyroid eye disease. Am J Pathol 186 (2016), 3189–3202.
214. Wölfle, U., Seelinger, G., Bauer, G., Meinke, M.C., Lademann, J., Schempp, C.M., Reactive molecule species and antioxidative mechanisms in normal skin and skin aging. Skin Pharmacol Physiol 27 (2014), 316–332.
215. Woods, S.L., Whitelaw, M.L., Differential activities of mouse single-minded 1 (SIM1) and SIM2 on a hypoxic response element. Cross-talk between basic helix-loop-helix/per-Arnt-sim homology transcription factors. J Biol Chem 277 (2002), 10236–10243.
216. Wu, D., Potluri, N., Kim, Y., Rastinejad, F., Structure and dimerization properties of the aryl hydrocarbon receptor PAS-A domain. Mol Cell Biol 33 (2013), 4346–4356.
217. Xiao, L., Zhang, Z., Luo, X., Roles of xenobiotic receptors in vascular pathophysiology. Circ J 78 (2014), 1520–1530.
218. Zack, J.A., Suskind, R.R., The mortality experience of workers exposed to tetrachlorodibenzodioxin in a trichlorophenol process accident. J Occup Med 22 (1980), 11–14.
219. Zhang, X., Lu, J., He, B., Tang, L., Liu, X., Zhu, D., et al., A tryptophan derivative, ITE, enhances liver cell metabolic functions in vitro. Int J Mol Med 39 (2017), 101–112.
220. Zhang, Y., Dong, S., Wang, H., Tao, S., Kiyama, R., Biological impact of environmental polycyclic aromatic hydrocarbons (ePAHs) as endocrine disruptors. Environ Pollut 213 (2016), 809–824.
221. Zhu, C., Chen, Y.L., Wang, X.J., Hu, X.S., Yu, Z.B., Han, S.P., shRNA-mediated gene silencing of AHR promotes the differentiation of P19 mouse embryonic carcinoma cells into cardiomyocytes. Mol Med Rep 6 (2012), 513–518.
222. Kim, J.B., Pjanic, M., Nguyen, T., Miller, C.L., Iyer, D., Liu, B., Wang, T., Sazonova, O., Carcamo-Orive, I., Perisic Matic, L., Maegdefessel, L., Hedin, U., Quertermous, T., TCF21 and the environmental sensor aryl-hydrocarbon receptor cooperate to activate a pro-inflammatory gene expression program in coronary artery smooth muscle cells. PLoS Genet, 13, 2017, e1006750.